Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Gene Therapy
|
May 7, 2003
Targeting 'horror autotoxicus' by gene therapy: results, challenges and the future
L Layward, Y Chernajovsky
British Journal of Haematology
|
October 1, 1981
Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia
L Layward, R J Levinsky, M Butler
Lancet (London, England)
|
October 21, 1978
Vascular permeability factor and nephrotic syndrome
R S Trompeter, T M Barratt, L Layward
Molecular Medicine Today
|
October 2, 1998
Multiple sclerosis: modelling the future. The Multiple Sclerosis Society of Great Britain and Northern Ireland Conference: Frontiers in Science and Patient Care Disease Management
S Amor, L Layward, J M van Noort
Clinical and Experimental Immunology
|
December 1, 1978
Primary and secondary abnormalities of T cell subpopulations
R S Trompeter, L Layward, A R Hayward
Clinical and Experimental Immunology
|
January 1, 1981
T lymphocyte mobility: defects and effects of ascorbic acid, histamine and complexed IgG
E M Smogorzewska, L Layward, J F Soothill
Biochemical Society Transactions
|
May 1, 1997
Protective mechanisms by omega-6 lipids in experimental autoimmune encephalomyelitis (EAE) are associated with cytokines and eicosanoids
L S Harbige, L Layward, M Morris, et al.
Experimental Nephrology
|
May 1, 1994
In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy
A C Allen, L Layward, S J Harper, et al.
Clinical and Experimental Immunology
|
January 1, 1981
Growth of pre-B cells in cultures of bone marrow from children with acute lymphoblastic leukaemia and other diseases
P Paolucci, N T Rapson, L Layward, et al.
Biochemical Society Transactions
|
May 1, 1997
Cytokine secretion by human T cell clones is differentially regulated by eicosanoids
L S Harbige, L Layward, M M Morris, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Gene Therapy
|
May 7, 2003
Targeting 'horror autotoxicus' by gene therapy: results, challenges and the future
L Layward, Y Chernajovsky
British Journal of Haematology
|
October 1, 1981
Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia
L Layward, R J Levinsky, M Butler
Lancet (London, England)
|
October 21, 1978
Vascular permeability factor and nephrotic syndrome
R S Trompeter, T M Barratt, L Layward
Molecular Medicine Today
|
October 2, 1998
Multiple sclerosis: modelling the future. The Multiple Sclerosis Society of Great Britain and Northern Ireland Conference: Frontiers in Science and Patient Care Disease Management
S Amor, L Layward, J M van Noort
Clinical and Experimental Immunology
|
December 1, 1978
Primary and secondary abnormalities of T cell subpopulations
R S Trompeter, L Layward, A R Hayward
Clinical and Experimental Immunology
|
January 1, 1981
T lymphocyte mobility: defects and effects of ascorbic acid, histamine and complexed IgG
E M Smogorzewska, L Layward, J F Soothill
Biochemical Society Transactions
|
May 1, 1997
Protective mechanisms by omega-6 lipids in experimental autoimmune encephalomyelitis (EAE) are associated with cytokines and eicosanoids
L S Harbige, L Layward, M Morris, et al.
Experimental Nephrology
|
May 1, 1994
In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy
A C Allen, L Layward, S J Harper, et al.
Clinical and Experimental Immunology
|
January 1, 1981
Growth of pre-B cells in cultures of bone marrow from children with acute lymphoblastic leukaemia and other diseases
P Paolucci, N T Rapson, L Layward, et al.
Biochemical Society Transactions
|
May 1, 1997
Cytokine secretion by human T cell clones is differentially regulated by eicosanoids
L S Harbige, L Layward, M M Morris, et al.
Page
of 4